Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Phoenix Education Partners heads into its November earnings with analysts steadily lowering the bar, the stock sitting well below consensus targets, and a concentrated ownership structure that gives the float an unusual character.
The analyst picture is one of contained optimism turning more cautious on valuation. Every firm covering the stock maintains a positive rating: BMO Capital kept its Outperform, B. Riley holds a Buy, Barrington Research and Morgan Stanley both carry bullish calls. But the direction of travel on price targets has been consistently lower. BMO's Jeffrey Silber trimmed his target to $33 from $36 this week, the most recent in a string of cuts. B. Riley dropped its target to $51 from $54 back in July. Goldman Sachs, which has a more sceptical Neutral rating, lowered its target to $36 from $42 last November. The consensus mean target sits at $41, implying roughly 58% upside from the $26.01 close, a gap wide enough to flag. With most targets clustering in the $33 to $51 range and the stock trading at $26, either the Street sees something not yet priced, or the targets are being walked down toward where the stock actually is. Bulls point to employer partnerships and online education tailwinds. Bears flag student retention and graduation rates as the persistent overhang on growth assumptions.
Valuation at these levels is genuinely cheap on the numbers available. The stock trades at a PE of around 5.3 and EV/EBITDA of roughly 3.1, both of which have drifted slightly higher over the past month as the share price recovered from its lows. The price-to-book ratio is 1.7. For a company with a credible institutional register, these multiples reflect either deep scepticism about earnings quality or the simple reality that with Apollo Global Management holding 69% of the shares outstanding, the free float is extremely thin. With The Vistria Group holding a further 13.7%, the two largest shareholders account for roughly 83% of the company. That leaves a very small pool of shares actually trading.
Short positioning reflects the limited float rather than any aggressive bear thesis. Short interest amounts to about 2% of the free float, which is low and has actually edged down about 2% over the past week, though it is up around 9% over the past month. Borrowing is cheap at under 1%, and availability is ample at over 208%, meaning there are more than twice as many shares available to borrow as there are currently borrowed. The short score of 68.7 out of 100 sits in elevated territory relative to the wider market but has come down from a peak of 73.4 on September 25. The borrow market is in no way stressed.
The insider data for the period to late August shows option exercises and tax-withholding transactions from the CEO, Chief Operating Officer, Chief Legal Officer and Chief Human Resources Officer, all in the same compensation-cycle pattern. Transaction codes M (option exercise) and F (shares withheld for tax) dominate the recent filings, with the net 90-day position effectively flat. None of these are open-market purchases, so they carry little signal about management conviction at current prices.
On the week, PXED gained 3.6% to reach $26.01, broadly in line with peers. APEI led the education group with a 9.5% weekly gain. PRDO rose 5.6% and STRA added 3.3%, so PXED's move was a mid-pack performance rather than a standout. The stock is still down around 6% over the past month and has fallen roughly 10% since July earnings, when it dropped 10% on the day of the print and was down another 0.3% by the end of that week. The next scheduled earnings date is November 20, which sets a clear focal point for the near term.
With targets being trimmed toward the stock's current trading range and the next print six weeks out, the gap between the Street's stated upside and where the targets are actually heading is the clearest tension worth watching.
See the live data behind this article on ORTEX.
Open PXED on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
